RT Journal Article
SR Electronic
T1 Correction: <em>Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy</em>
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001089corr1
DO 10.1136/jitc-2020-001089corr1
VO 8
IS 2
YR 2020
UL http://jitc.bmj.com/content/8/2/e001089corr1.abstract